Mediaseed - Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo

Your Email:

Password:

Email:

Thank you!

A password reset link has been sent to your email address

Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo

New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstructive pulmonary disease (COPD) who took CHANTIX/CHAMPIX® (varenicline) were able to quit smoking and remain abstinent during the last four weeks of treatment (weeks 9-12) compared with 8.8 percent of those given placebo (p<0.0001). These findings were presented by investigators at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP).

Important Safety Information
Please click here for Full Prescribing Information and Medication Guide.

Email A Colleague


		Recipient:
		Your Email:
		Message:

Comment On Story

Embed Video

You can copy and paste this EMBED code into your website or blog.

Download Now Add to Basket

Macromedia Flash	300 KBps \| 25 MB
Windows Video (WMV)	82 MB

Email

[8]

Broadcast Video[2]

Donald P. Tashkin, M.D., Primary Study Investigator, Emeritus Professor of Medicine at UCLA Important Safety Information For Full Prescribing Information and Patient Medication Guide, please copy and paste the following links into your web browser: http://www.pfizer.com/files/products/uspi_chantix.pdf and http://www.pfizer.com/files/products/ppi_chantix.pdf, respectively.

You are now previewing this video in the flash player above.

Preview Asset

You cannot preview this asset unless you are logged in.

Download Now Add to Basket

Macromedia Flash	300 KBps \| 25 MB
Windows Video (WMV)	82 MB

CHANTIX bottle[1]

Important Safety Information For Full Prescribing Information and Patient Medication Guide, please copy and paste the following links into your web browser: http://www.pfizer.com/files/products/uspi_chantix.pdf and http://www.pfizer.com/files/products/ppi_chantix.pdf, respectively.

You are now previewing this video in the flash player above.

Preview Asset

You cannot preview this asset unless you are logged in.

Download Now Add to Basket

JPG Image

72 Dpi | 35 KB

CHANTIX starter pack[2]

You are now previewing this video in the flash player above.

Preview Asset

You cannot preview this asset unless you are logged in.

Download Now Add to Basket

JPG Image	72 Dpi \| 57 KB
JPG Image	300 Dpi \| 404 KB

CHANTIX (Varenicline) Fact Sheet[1]

You are now previewing this video in the flash player above.

Preview Asset

You cannot preview this asset unless you are logged in.

Download Now Add to Basket

Acrobat

149 KB

PDF[1]

COPD and Smoking Global Fact Sheet

You are now previewing this video in the flash player above.

Preview Asset

You cannot preview this asset unless you are logged in.

Download Now Add to Basket

Acrobat

43 KB

PDF[1]

Full Prescribing Information for CHANTIX (varenicline)

You are now previewing this video in the flash player above.

Preview Asset

You cannot preview this asset unless you are logged in.

Download Now Add to Basket

Acrobat

422 KB

PDF[1]

Patient Medication Guide for CHANTIX (varenicline)

You are now previewing this video in the flash player above.

Preview Asset

You cannot preview this asset unless you are logged in.

Download Now Add to Basket

Acrobat

40 KB

Logo[2]

Pfizer Logo

You are now previewing this video in the flash player above.

Preview Asset

You cannot preview this asset unless you are logged in.

Download Now Add to Basket

JPG Image	10 KB
JPG Image	300 Dpi \| 114 KB

All content on this site is provided by the sources noted, and unless otherwise indicated is available for free and unrestricted use. Mediaseed is a service of Medialink.

All Topics My Topics

Please select the categories you wish to view and click the search arrow above.

Corporate News & Issues

Financial

Products

Research & Development

Animal Health

Photos/Images

All product names, whether or not appearing in large print or with the trademark symbol, are trademarks owned by or licensed to Pfizer Inc. its affiliates, subsidiaries or related companies, unless otherwise noted. The Pfizer trademarks, trade names, trade dress and other material contained on this website are provided by Pfizer for use by media professionals only in order to identify the products or services of the company. All other use of Pfizer trademarks, trade name, trade dress or other material requires the prior written authorization of Pfizer Inc. The use or misuse of Pfizer trademarks, trade names, trade dress or any other material, except as permitted herein, is expressly prohibited.

Return to Pfizer.com